Shintaro Yamazaki

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. Mitsuka Y, Yamazaki S, Yoshida N, Masamichi M, Higaki T, Takayama T. Prospective Validation of Optimal Drain Management "The 3 × 3 Rule" after Liver Resection. World J Surg. 2016;40:2213-20 pubmed publisher
    ..This test set predicts that 274 of 316 patients (87.0 %) will be safely managed without adverse events when drain management is performed without deviation from the rule...
  2. Okada S, Yamazaki S, Kaiga T, Funada T, Kochi M, Takayama T. Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy. World J Surg Oncol. 2017;15:162 pubmed publisher
    ..01) and 5-year OS (26.5 vs. 11.1%, p = 0.01) are significantly better in the well-nourished group. The well-nourished at initial 6 months may predict a better treatment response and fewer adverse events in FOLFOX/FIRI chemotherapy. ..

Detail Information

Publications2

  1. Mitsuka Y, Yamazaki S, Yoshida N, Masamichi M, Higaki T, Takayama T. Prospective Validation of Optimal Drain Management "The 3 × 3 Rule" after Liver Resection. World J Surg. 2016;40:2213-20 pubmed publisher
    ..This test set predicts that 274 of 316 patients (87.0 %) will be safely managed without adverse events when drain management is performed without deviation from the rule...
  2. Okada S, Yamazaki S, Kaiga T, Funada T, Kochi M, Takayama T. Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy. World J Surg Oncol. 2017;15:162 pubmed publisher
    ..01) and 5-year OS (26.5 vs. 11.1%, p = 0.01) are significantly better in the well-nourished group. The well-nourished at initial 6 months may predict a better treatment response and fewer adverse events in FOLFOX/FIRI chemotherapy. ..